199 related articles for article (PubMed ID: 28933018)
1. [
Puri T; Greenhalgh TA; Wilson JM; Franklin J; Wang LM; Strauss V; Cunningham C; Partridge M; Maughan T
EJNMMI Res; 2017 Sep; 7(1):78. PubMed ID: 28933018
[TBL] [Abstract][Full Text] [Related]
2. The role of sequential 18(F) -FDG PET/CT in predicting tumour response after preoperative chemoradiation for rectal cancer.
Sun W; Xu J; Hu W; Zhang Z; Shen W
Colorectal Dis; 2013 May; 15(5):e231-8. PubMed ID: 23384167
[TBL] [Abstract][Full Text] [Related]
3. Monitoring early response to chemoradiotherapy with
Grkovski M; Lee NY; Schöder H; Carlin SD; Beattie BJ; Riaz N; Leeman JE; O'Donoghue JA; Humm JL
Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1682-1691. PubMed ID: 28540417
[TBL] [Abstract][Full Text] [Related]
4. High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer.
Okamoto S; Shiga T; Yasuda K; Ito YM; Magota K; Kasai K; Kuge Y; Shirato H; Tamaki N
J Nucl Med; 2013 Feb; 54(2):201-7. PubMed ID: 23321456
[TBL] [Abstract][Full Text] [Related]
5. Residual tumour hypoxia in head-and-neck cancer patients undergoing primary radiochemotherapy, final results of a prospective trial on repeat FMISO-PET imaging.
Löck S; Perrin R; Seidlitz A; Bandurska-Luque A; Zschaeck S; Zöphel K; Krause M; Steinbach J; Kotzerke J; Zips D; Troost EGC; Baumann M
Radiother Oncol; 2017 Sep; 124(3):533-540. PubMed ID: 28843726
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric Imaging of Tumor Hypoxia and Perfusion with
Grkovski M; Schöder H; Lee NY; Carlin SD; Beattie BJ; Riaz N; Leeman JE; O'Donoghue JA; Humm JL
J Nucl Med; 2017 Jul; 58(7):1072-1080. PubMed ID: 28183993
[TBL] [Abstract][Full Text] [Related]
7. To Explore a Representative Hypoxic Parameter to Predict the Treatment Response and Prognosis Obtained by [
Li L; Wei Y; Huang Y; Yu Q; Liu W; Zhao S; Zheng J; Lu H; Yu J; Yuan S
Mol Imaging Biol; 2018 Dec; 20(6):1061-1067. PubMed ID: 29623510
[TBL] [Abstract][Full Text] [Related]
8. Textural features of hypoxia PET predict survival in head and neck cancer during chemoradiotherapy.
Sörensen A; Carles M; Bunea H; Majerus L; Stoykow C; Nicolay NH; Wiedenmann NE; Vaupel P; Meyer PT; Grosu AL; Mix M
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1056-1064. PubMed ID: 31773233
[TBL] [Abstract][Full Text] [Related]
9. Influence of the scan time point when assessing hypoxia in
Kobayashi K; Manabe O; Hirata K; Yamaguchi S; Kobayashi H; Terasaka S; Toyonaga T; Furuya S; Magota K; Kuge Y; Kudo K; Shiga T; Tamaki N
Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1833-1842. PubMed ID: 31781832
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Optimal Post-Injection Timing of Hypoxic Imaging with
Kawamura M; Yoshimura M; Shimizu Y; Sano K; Ishimori T; Nakamoto Y; Mizowaki T; Hiraoka M
Mol Imaging Biol; 2021 Aug; 23(4):597-603. PubMed ID: 33475945
[TBL] [Abstract][Full Text] [Related]
11. Whole tumor kinetics analysis of
McGowan DR; Skwarski M; Papiez BW; Macpherson RE; Gleeson FV; Schnabel JA; Higgins GS; Fenwick JD
EJNMMI Res; 2018 Aug; 8(1):73. PubMed ID: 30069753
[TBL] [Abstract][Full Text] [Related]
12. Comparison of three
Dos Santos SN; Wuest M; Jans HS; Woodfield J; Nario AP; Krys D; Dufour J; Glubrecht D; Bergman C; Bernardes ES; Wuest F
Nucl Med Biol; 2023; 124-125():108383. PubMed ID: 37651917
[TBL] [Abstract][Full Text] [Related]
13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
14. Biological image-guided radiotherapy in rectal cancer: is there a role for FMISO or FLT, next to FDG?
Roels S; Slagmolen P; Nuyts J; Lee JA; Loeckx D; Maes F; Stroobants S; Penninckx F; Haustermans K
Acta Oncol; 2008; 47(7):1237-48. PubMed ID: 18654902
[TBL] [Abstract][Full Text] [Related]
15. Tumour hypoxia imaging with 18F-fluoroazomycinarabinofuranoside PET/CT in patients with locally advanced rectal cancer.
Havelund BM; Holdgaard PC; Rafaelsen SR; Mortensen LS; Theil J; Bender D; Pløen J; Spindler KL; Jakobsen A
Nucl Med Commun; 2013 Feb; 34(2):155-61. PubMed ID: 23196674
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic Analysis of Dynamic
Schwartz J; Grkovski M; Rimner A; Schöder H; Zanzonico PB; Carlin SD; Staton KD; Humm JL; Nehmeh SA
J Nucl Med; 2017 Jun; 58(6):911-919. PubMed ID: 28232611
[TBL] [Abstract][Full Text] [Related]
17. Predicting complete response to neoadjuvant CRT for distal rectal cancer using sequential PET/CT imaging.
Perez RO; Habr-Gama A; São Julião GP; Lynn PB; Sabbagh C; Proscurshim I; Campos FG; Gama-Rodrigues J; Nahas SC; Buchpiguel CA
Tech Coloproctol; 2014 Aug; 18(8):699-708. PubMed ID: 24509716
[TBL] [Abstract][Full Text] [Related]
18.
Furuya S; Naya M; Manabe O; Hirata K; Ohira H; Aikawa T; Koyanagawa K; Magota K; Tsujino I; Anzai T; Kuge Y; Oyama-Manabe N; Kudo K; Shiga T; Tamaki N
J Nucl Cardiol; 2021 Oct; 28(5):2141-2148. PubMed ID: 31820409
[TBL] [Abstract][Full Text] [Related]
19. Evaluating cardiac hypoxia in hibernating myocardium: Comparison of
Jagtap R; Asopa RV; Basu S
World J Nucl Med; 2019; 18(1):30-35. PubMed ID: 30774543
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Hypermetabolic and Hypoxic Volumes Delineated on [
Thureau S; Modzelewski R; Bohn P; Hapdey S; Gouel P; Dubray B; Vera P
Mol Imaging Biol; 2020 Jun; 22(3):764-771. PubMed ID: 31432388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]